Skip to content

The safety and efficacy of concentration growth factor partly injection in white hair

The safety and efficacy of concentration growth factor partly injection in white hair

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047179
Enrollment
Unknown
Registered
2021-06-10
Start date
2021-06-10
Completion date
Unknown
Last updated
2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

white hair

Interventions

experimental group:concentrated growth factor
control group:Nil

Sponsors

Xiangyang First People's Hospital Affiliated Hospital of Hubei University of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 45 to 70 years; 2. The number of white hair at the line from ear edge to eyebrow arch is more than 20%; 3. Have the need and willingness to turn white hair black, voluntarily sign the informed consent of clinical trial, and can actively cooperate with treatment and visitors; 4. No deformity, scar, alopecia areata or hair loss on the left and right scalp; 5. No diseases of the skin system; 6. The ongoing treatment of the subject has no effect on this study.

Exclusion criteria

Exclusion criteria: 1.Have received hair transplantation, hair coloring, perm, traditional Chinese medicine and other drugs to promote hair regeneration and blackening within 6 months before the date of operation; 2.Patients with white disease and vitiligo; 3.During the trial, there were violent scalp and hair root traction, trauma, infection, facial neuritis, trigeminal neuralgia; 4.Ultraviolet light sensitivity, scar constitution; 5.Pregnant or lactating women, women who plan to become pregnant during the study period; 6.Coagulation dysfunction; 7.Autoimmune diseases such as: Hashimoto's disease, rheumatoid arthritis; 8.Patients suffering from serious organic diseases, such as coronary heart disease, hypertension, diabetes, pulmonary dysfunction and other unstable disease control; 9.Malignant tumor; 10.People suffering from acute or chronic infectious diseases, mental diseases and mental disorders; 11.Undernourished, stressed and emotionally unstable.

Design outcomes

Secondary

MeasureTime frame
Local number of white hair;Local number of black hair;Quantitative assessment of hair growth;

Primary

MeasureTime frame
Number of hair changes from white to black in the intervention area;

Countries

China

Contacts

Public ContactPei Bin

Xiangyang First People’s Hospital Affiliated Hospital of Hubei University of Medicine

binpei@hbmu.edu.cn+86 18995678520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026